Cashu | News | LLY

HomeWatchlistNewsSignalsPicks

DJI

+0.08%

SPX

-0.22%

IXIC

-0.51%

FTSE

-0.20%

N225

-0.22%

AXJO

-0.21%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Lilly(Eli) & Company News

Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere

Feature Image for interests on Biotech, Briefs, Healthcare, Ireland from benzinga.com

about 2 hours ago

3 'Underdog Stocks' For The Rest Of 2025

Feature Image for interests on Communication Services, Consumer Cyclical, Expert Ideas, Healthcare from benzinga.com

about 3 hours ago

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering

Feature Image for interests on Biotech, Briefs, China, Fda from benzinga.com

about 3 hours ago

RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome

Feature Image for interests on Biotechnology, Computer & Electronics, Health Care & Hospitals, Healthcare from prnewswire.com

Wisner Baum: Ninth Circuit Affirms Actos RICO Class Action Certification Against Takeda and Eli Lilly

Feature Image for interests on Health Care & Hospitals, Healthcare, Legal Issues, Stock from prnewswire.com

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst

Feature Image for interests on Analyst Color, Biotech, Briefs, Expert Ideas from benzinga.com

Stocks making the biggest moves midday: Nucor, Sunrun, Affirm, Zoetis, Circle and more

Feature Image for interests on Basic Materials, Breaking News: Markets, Business, Consumer Discretionary from cnbc.com

Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study

Feature Image for interests on Biotech, Briefs, Healthcare, News from benzinga.com

Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal

Feature Image for interests on Breaking News: Markets, Healthcare, Investment Strategy, Markets from cnbc.com

Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday

Latest Cashu News

Eli Lilly Expands Access to Zepbound for Obesity Treatment with New Dosage Options

Eli Lilly Enhances Obesity Treatment Access with Zepbound Initiative and Expanded Doses

Eli Lilly Partners with Chugai to Tackle Obesity and Muscle Wasting

Stocks

Health Care

lly

Lilly(Eli) & Company

LLY

-23.04 (-2.93%)

761.99

USD

At close at Jun 20, 20:34 UTC